A Phase 2B prospective, blinded, randomized, placebo controlled, international multicenter study to assess restoration of coronary artery blood flow and resolution of ST segment deviation after a single subcutaneous injection of RUC-4 in subjects with ST-elevation myocardial infarction presenting in the ambulance (pre-hospital setting).
This multi-center study designed to enroll 1668 subjects will be conducted at up to 15 clinical sites (hospitals/ambulance services) in the Netherlands and Czech Republic.
